{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:33:26Z","timestamp":1776332006680,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11899-022-00666-4","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T08:03:08Z","timestamp":1656144188000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms"],"prefix":"10.1007","volume":"17","author":[{"given":"Mia J.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-4170","authenticated-orcid":false,"given":"Juliana Perez","family":"Botero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"issue":"1","key":"666_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","volume":"88","author":"T Pippucci","year":"2011","unstructured":"Pippucci T, et al. Mutations in the 5\u2019 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet. 2011;88(1):115\u201320.","journal-title":"Am J Hum Genet"},{"key":"666_CR2","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Bluteau D, et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest, 2014. 124(2): 580\u201391. Defines the molecular mechanisms of disease in ANKRD26-RT.","DOI":"10.1172\/JCI71861"},{"issue":"5","key":"666_CR3","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/302637","volume":"65","author":"A Savoia","year":"1999","unstructured":"Savoia A, et al. An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p. Am J Hum Genet. 1999;65(5):1401\u20135.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"666_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1182\/blood.V96.1.118","volume":"96","author":"JG Drachman","year":"2000","unstructured":"Drachman JG, Jarvik GP, Mehaffey MG. Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood. 2000;96(1):118\u201325.","journal-title":"Blood"},{"issue":"1","key":"666_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000071812","volume":"55","author":"MJ Gandhi","year":"2003","unstructured":"Gandhi MJ, Cummings CL, Drachman JG. FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10. Hum Hered. 2003;55(1):66\u201370.","journal-title":"Hum Hered"},{"issue":"9","key":"666_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/j.1538-7836.2010.03979.x","volume":"8","author":"F Punzo","year":"2010","unstructured":"Punzo F, et al. A mutation in the acyl-coenzyme A binding domain-containing protein 5 gene (ACBD5) identified in autosomal dominant thrombocytopenia. J Thromb Haemost. 2010;8(9):2085\u20137.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"666_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5482\/ha12050001","volume":"32","author":"CL Balduini","year":"2012","unstructured":"Balduini CL, Pecci A, Noris P. Inherited thrombocytopenias: the evolving spectrum. Hamostaseologie. 2012;32(4):259\u201370.","journal-title":"Hamostaseologie"},{"issue":"12","key":"666_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00439-012-1215-x","volume":"131","author":"CL Balduini","year":"2012","unstructured":"Balduini CL, Savoia A. Genetics of familial forms of thrombocytopenia. Hum Genet. 2012;131(12):1821\u201332.","journal-title":"Hum Genet"},{"key":"666_CR9","doi-asserted-by":"crossref","unstructured":"Mazharian A, Watson SP, and Severin S. Critical role for ERK1\/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Exp Hematol, 2009. 37(10): 1238\u20131249 e5.","DOI":"10.1016\/j.exphem.2009.07.006"},{"issue":"11","key":"666_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ejmg.2018.01.014","volume":"61","author":"A Balduini","year":"2018","unstructured":"Balduini A, et al. Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related thrombocytopenia and MYH9-related diseases. Eur J Med Genet. 2018;61(11):715\u201322.","journal-title":"Eur J Med Genet"},{"key":"666_CR11","doi-asserted-by":"crossref","unstructured":"Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: who and how to test. J Thromb Haemost, 2021;19(9): 2127\u20132136.","DOI":"10.1111\/jth.15484"},{"key":"666_CR12","unstructured":"\u2022\u2022 Noris P, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood, 2011;117(24):6673\u201380. Largest clinical cohort presenting clinical, laboratory and molecular characterization of patients with ANKRD26-RT."},{"issue":"7","key":"666_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/09537104.2016.1171305","volume":"27","author":"J Perez Botero","year":"2016","unstructured":"Perez Botero J, et al. Clinical and laboratory characteristics in congenital ANKRD26 mutation-associated thrombocytopenia: a detailed phenotypic study of a family. Platelets. 2016;27(7):712\u20135.","journal-title":"Platelets"},{"key":"666_CR14","doi-asserted-by":"crossref","unstructured":"Sharma R, Perez Botero J, Jobe SM. Congenital disorders of platelet function and number. Pediatr Clin North Am, 2018;65(3): 561\u2013578.","DOI":"10.1016\/j.pcl.2018.02.009"},{"issue":"5","key":"666_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ng.3253","volume":"47","author":"L Noetzli","year":"2015","unstructured":"Noetzli L, et al. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet. 2015;47(5):535\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"666_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","volume":"122","author":"P Noris","year":"2013","unstructured":"Noris P, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122(11):1987\u20139.","journal-title":"Blood"},{"issue":"8","key":"666_CR17","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ejhg.2008.89","volume":"16","author":"M Beri-Dexheimer","year":"2008","unstructured":"Beri-Dexheimer M, et al. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet. 2008;16(8):1014\u20138.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"666_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/leu.2015.236","volume":"30","author":"I Antony-Debre","year":"2016","unstructured":"Antony-Debre I, et al. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia. Leukemia. 2016;30(4):999\u20131002.","journal-title":"Leukemia"},{"issue":"11","key":"666_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ajh.26321","volume":"96","author":"ES Martin","year":"2021","unstructured":"Martin ES, et al. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes. Am J Hematol. 2021;96(11):1450\u201360.","journal-title":"Am J Hematol"},{"key":"666_CR20","doi-asserted-by":"crossref","unstructured":"\u2022 Downes K, et al. Clinical management, ethics and informed consent related to multi-gene panel-based high throughput sequencing testing for platelet disorders: communication from the SSC of the ISTH. J Thromb Haemost, 2020. 18(10):2751\u20132758. Consensus statement on informed consent for patients tested with multi-gene panels for inherited platelet disorders with specific focus on predisposition to maliganncy.","DOI":"10.1111\/jth.14993"},{"issue":"3","key":"666_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/gim.2012.176","volume":"15","author":"LF Ross","year":"2013","unstructured":"Ross LF, et al. Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15(3):234\u201345.","journal-title":"Genet Med"},{"key":"666_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.41","volume":"5","author":"J Perez Botero","year":"2015","unstructured":"Perez Botero J, et al. ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26. Blood Cancer J. 2015;5: e315.","journal-title":"Blood Cancer J"},{"issue":"5","key":"666_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"23","key":"666_CR24","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, et al. ClinGen\u2013the Clinical Genome Resource. N Engl J Med. 2015;372(23):2235\u201342.","journal-title":"N Engl J Med"},{"issue":"10","key":"666_CR25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00431-015-2549-x","volume":"174","author":"H Boutroux","year":"2015","unstructured":"Boutroux H, et al. Childhood diagnosis of genetic thrombocytopenia with mutation in the ankyrine repeat domain 26 gene. Eur J Pediatr. 2015;174(10):1399\u2013403.","journal-title":"Eur J Pediatr"},{"key":"666_CR26","doi-asserted-by":"crossref","unstructured":"Ferrari S, et al. Spectrum of 5'UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected. Platelets, 2017;28(6):621\u2013624.","DOI":"10.1080\/09537104.2016.1267337"},{"issue":"7809","key":"666_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"key":"666_CR28","doi-asserted-by":"crossref","unstructured":"DeSanto C, et al. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome. J Med Genet, 2015. 52(11):754\u201361.","DOI":"10.1136\/jmedgenet-2015-103069"},{"issue":"3","key":"666_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2013-03-489344","volume":"122","author":"SA Al Daama","year":"2013","unstructured":"Al Daama SA, et al. A missense mutation in ANKRD26 segregates with thrombocytopenia. Blood. 2013;122(3):461\u20132.","journal-title":"Blood"},{"key":"666_CR30","doi-asserted-by":"crossref","unstructured":"\u2022 Wahlster L, et al. Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript. J Exp Med, 2021. 218(6). Case of ANKRD26-RT caused by a structural varaint out side of the 5\u2032 UTR where all most disease causing variants cluster.","DOI":"10.1084\/jem.20210444"},{"issue":"1","key":"666_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-016-0382-y","volume":"10","author":"C Marconi","year":"2017","unstructured":"Marconi C, et al. 5\u2019UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. J Hematol Oncol. 2017;10(1):18.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"666_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng.3469","volume":"48","author":"R Rahbari","year":"2016","unstructured":"Rahbari R, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48(2):126\u201333.","journal-title":"Nat Genet"},{"issue":"7","key":"666_CR33","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.mayocp.2019.12.013","volume":"95","author":"AA Mangaonkar","year":"2020","unstructured":"Mangaonkar AA, Patnaik MM. Hereditary predisposition to hematopoietic neoplasms: when bloodline matters for blood cancers. Mayo Clin Proc. 2020;95(7):1482\u201398.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"666_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12185-013-1351-7","volume":"98","author":"A Pecci","year":"2013","unstructured":"Pecci A. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists. Int J Hematol. 2013;98(1):34\u201347.","journal-title":"Int J Hematol"},{"issue":"4","key":"666_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.seminhematol.2014.08.001","volume":"51","author":"LA Godley","year":"2014","unstructured":"Godley LA. Inherited predisposition to acute myeloid leukemia. Semin Hematol. 2014;51(4):306\u201321.","journal-title":"Semin Hematol"},{"issue":"25","key":"666_CR36","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1182\/blood-2013-06-506873","volume":"122","author":"J Stockley","year":"2013","unstructured":"Stockley J, et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013;122(25):4090\u20133.","journal-title":"Blood"},{"issue":"2","key":"666_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2141.1991.tb04529.x","volume":"79","author":"JM Gerrard","year":"1991","unstructured":"Gerrard JM, et al. Inherited platelet-storage pool deficiency associated with a high incidence of acute myeloid leukaemia. Br J Haematol. 1991;79(2):246\u201355.","journal-title":"Br J Haematol"},{"issue":"8","key":"666_CR38","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1080\/10428194.2016.1265118","volume":"58","author":"J Perez Botero","year":"2017","unstructured":"Perez Botero J, et al. Clinical characteristics and platelet phenotype in a family with RUNX1 mutated thrombocytopenia. Leuk Lymphoma. 2017;58(8):1963\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"666_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005262","volume":"11","author":"S Topka","year":"2015","unstructured":"Topka S, et al. Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia. PLoS Genet. 2015;11(6): e1005262.","journal-title":"PLoS Genet"},{"issue":"2","key":"666_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3177","volume":"47","author":"MY Zhang","year":"2015","unstructured":"Zhang MY, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47(2):180\u20135.","journal-title":"Nat Genet"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-022-00666-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-022-00666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:48:21Z","timestamp":1663850901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-022-00666-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1007\/s11899-022-00666-4","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"29 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}